|
|
 |
|
Viewing report
|
|
|
|
Drugs of Tomorrow 2001: Diabetes
Datamonitor, Jan 2002
The key unmet need in the diabetes market is centred around drug delivery formulations. Insulin, not only the gold standard treatment for type I diabetes, but also an increasingly recommended treatment for type II diabetes, must be administered by injection. Injection drug delivery is painful for and unpopular with patients, and results in poor compliance. The current insulins on the market face increasing threat of competition from products in the R&D pipeline which address this unmet needs. Indeed, the imminent arrival of the inhalation and oral insulins, which, for the first time, offer patients requiring insulin therapy a means of administering the drug by a formulation other than injection could change the face of insulin therapy and of the diabetes market as a whole. However, by no means do pipeline drugs address all the unmet needs in the current diabetes market: analysis of the pipeline highlights the gaps that remain and the potential available to the drug developer. Drugs of Tomorrow 2001: Diabetes provides an in-depth, critical evaluation of the key R&D compounds currently in development for the treatment of type I and II diabetes. In particular, the report evaluates the commercial prospects for the launch of innovative new products against the level of existing unmet needs in the diabetes market.
Customers who bought this item also bought
Br Malls Participacoes Sa
Br. Holdings Corporation
Market Dynamics 2001: Diabetes
Drugs of Tomorrow 2002: Depression - A pipeline driven by side effect profile
Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline Facing Chronic Unmet Needs
Drugs of Tomorrow 2001: Anticoagulants - A pipeline flowing with future blockbusters
Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs
Drugs of Tomorrow 2001: Antipsychotics - New Players in an Expanding Market
Treatment Algorithm 2001: Diabetes
Treatment Algorithms 2001: Schizophrenia - The Rise of Atypical Neuroleptics as the Physicians’ Favorite
Strategic Perspectives 2001: Narcolepsy - Specific Drugs are Waking up the Market
Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed
|
|
|
|
